Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study

Sadanori Okada(Hyogo Medical University), Mio Sakuma(Hyogo Medical University), Hirofumi Soejima(Kumamoto Health Science University), Hisao Ogawa(Kumamoto University Hospital), Hideaki Jinnouchi, Masako Waki(Shizuoka City Hospital), Masafumi Nakayama(Kumamoto University), Hitoshi Ishii(Nara Medical University), Yoshihiko Saito(National Archives and Records Administration), Yasuhiro Akai(Nara Medical University), Takeshi Morimoto(Hyogo Medical University)

PLoS ONE

January 25, 2016

10.1371/journal.pone.0147635

Cited by 31

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

|New England Journal of Medicine|2017|9.1k

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

|Circulation|1994|1.3k

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

|The Lancet|2017|1.3k

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

|The Lancet|2017|881

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

|JAMA|2019|848